EyePoint
Retinal disease therapeutics development
- B2B
About EyePoint
Developing and commercializing innovative treatments for serious retinal diseases, specifically wet age-related macular degeneration and diabetic macular edema, using sustained delivery technology.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Watertown, Massachusetts, United States
- Revenue
- $31.4MFY2025, publicly reported
- Website
- eyepoint.bio
- linkedin.com/company/eyepointbio
EyePoint at a glance
EyePoint is a B2B company in the Biotechnology Research industry, headquartered in Watertown, Massachusetts, United States.
EyePoint has 251–1,000 employees.
EyePoint's revenue is $31.4M (FY2025, publicly reported).
Selling to companies like EyePoint?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies